Evidence map›Paper›PMID 27014906›Full record

ArticleOncotarget2016

Unexpected positive control of NFκB and miR-155 by DGKα and ζ ensures effector and memory CD8+ T cell differentiation.

Jialong Yang, Ping Zhang, Sruti Krishna, Jinli Wang, Xingguang Lin, Hongxiang Huang, Danli Xie, Balachandra Gorentla, Rick Huang, Jimin Gao and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Non-coding RNAs in CD8 T cell biology.Molecular immunology · 2020
    Review
  8. Review
  9. Article
  10. Review
  11. DGKα in Neutrophil Biology and Its Implications for Respiratory Diseases.International journal of molecular sciences · 2019
    Review
  12. Article
  13. DGK α and ζ Activities Control TFrontiers in immunology · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Diacylglycerol Kinases in T Cell Tolerance and Effector Function.Frontiers in cell and developmental biology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Jialong YangDepartment of Pediatrics, Division of Allergy and Immunology, Duke University Medical Center, Durham, NC, USA.
Ping ZhangDepartment of Pediatrics, Division of Allergy and Immunology, Duke University Medical Center, Durham, NC, USA.
Sruti KrishnaDepartment of Pediatrics, Division of Allergy and Immunology, Duke University Medical Center, Durham, NC, USA.
Jinli WangSchool of Laboratory Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xingguang LinSchool of Laboratory Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Hongxiang HuangDepartment of Pediatrics, Division of Allergy and Immunology, Duke University Medical Center, Durham, NC, USA.
Danli XieDepartment of Pediatrics, Division of Allergy and Immunology, Duke University Medical Center, Durham, NC, USA.
Balachandra GorentlaDepartment of Pediatrics, Division of Allergy and Immunology, Duke University Medical Center, Durham, NC, USA.
Rick HuangDepartment of Pediatrics, Division of Allergy and Immunology, Duke University Medical Center, Durham, NC, USA.
Jimin GaoSchool of Laboratory Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Qi-Jing LiDepartment of Immunology, Duke University Medical Center, Durham, NC, USA.
Xiao-Ping ZhongDepartment of Pediatrics, Division of Allergy and Immunology, Duke University Medical Center, Durham, NC, USA.
Duke Medical Center · USWenzhou Medical University · CNDuke University Hospital · US

Funding

Regulation of peripheral T cell toleranceR01AI079088 · NIAID · DUKE UNIVERSITY · PI ZHONG, XIAOPING · 2008 to 2019
$3.5M
TSC1-mTOR signaling and T cell toleranceR01AI101206 · NIAID · DUKE UNIVERSITY · PI ZHONG, XIAOPING · 2012 to 2016
$1.9M
A Murine Model of Chronic Autoimmune Hepatitis and Liver FibrosisR01AI076357 · NIAID · DUKE UNIVERSITY · PI ZHONG, XIAOPING · 2008 to 2012
$1.5M
NIAID NIH HHS R01 AI076357NIAID NIH HHS R01 AI079088NIAID NIH HHS R01 AI101206
6 · The paper itself

Abstract

Signals from the T-cell receptor (TCR) and γ-chain cytokine receptors play crucial roles in initiating activation and effector/memory differentiation of CD8 T-cells. We report here that simultaneous deletion of both diacylglycerol kinase (DGK) α and ζ (DKO) severely impaired expansion of CD8 effector T cells and formation of memory CD8 T-cells after Listeria monocytogenes infection. Moreover, ablation of both DGKα and ζ in preformed memory CD8 T-cells triggered death and impaired homeostatic proliferation of these cells. DKO CD8 T-cells were impaired in priming due to decreased expression of chemokine receptors and migration to the draining lymph nodes. Moreover, DKO CD8 T-cells were unexpectedly defective in NFκB-mediated miR-155 transcript, leading to excessive SOCS1 expression and impaired γ-chain cytokine signaling. Our data identified a DGK-NFκB-miR-155-SOCS1 axis that bridges TCR and γ-chain cytokine signaling for robust CD8 T-cell primary and memory responses to bacterial infection.

Indexed as

AnimalsCD8-Positive T-LymphocytesCell DifferentiationChemotaxis, LeukocyteDiacylglycerol KinaseImmunologic MemoryListeria monocytogenesListeriosisLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutMicroRNAsNF-kappa BSignal TransductionDiacylglycerol Kinasediacylglycerol kinase zeta, mouseMicroRNAsMirn155 microRNA, mouseNF-kappa BCD8 T cellDGKImmune responseImmunityImmunology and Microbiology SectionListeria monocytogenesmiR-155NFκB

Identifiers

PMID27014906
PMCPMC5085116
OpenAlexW2405728450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.